Knowledge, Activation, and Costs of the Pharmacists’ Pneumonia Prevention Program (PPPP): A Novel Senior Center Model to Promote Vaccination

Laura Pizzi, Katherine M. Prioli, Lynn Fields Harris, Elizabeth Cannon-Dang, Marie Marthol-Clark, Matt Alcusky, Megan McCoy, Jason J. Schafer

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Vaccination is the best way to prevent pneumococcal disease (PD), but 40% of older adults remain unvaccinated nationwide, with even greater nonvaccination rates among African Americans (AAs). Prior studies suggest that insufficient knowledge contributes to low vaccination rates. The Pharmacists’ Pneumonia Prevention Program (PPPP) was designed to improve older adults’ knowledge about PD and pneumococcal vaccination (PV). Objective: To measure PPPP’s effect on knowledge and activation in a predominantly AA population and determine program costs. Methods: PPPP uses a senior center model with a pharmacist presentation, actors’ skit, and small-group action planning. Knowledge about PD risk, transmission, symptoms, and PV side effects was assessed at baseline (BL), postintervention (PT), and 3 months (M3) and analyzed using an intention-to-treat (ITT) approach. Actions taken (got vaccinated, spoke to doctor or pharmacist, discussed with family/friends) were assessed at M3. PPPP costs ($US 2013) included staff time, PV, actor, and site fees. Results: Of 276 attending PPPP, 190 consented and were included in the ITT sample, which was largely black (80.5%) and female (76.3%) and had a mean age of 74.4 years. Knowledge improved by 46.8% (BL vs PT), with significant gains in all domains. At M3, knowledge improved by 54.2% vs BL, indicating sustained gains; 37.2% of previously unvaccinated participants reported receiving PV by M3. Program cost was $119 per attendee. Conclusion: PPPP significantly improved PD and PV knowledge. It could be delivered more efficiently by holding larger events on fewer dates, staffing with volunteers where appropriate, and utilizing a local pharmacy to manage the vaccine supply.

Original languageEnglish (US)
Pages (from-to)446-453
Number of pages8
JournalAnnals of Pharmacotherapy
Volume52
Issue number5
DOIs
StatePublished - May 1 2018

Fingerprint

Senior Centers
Pharmacists
Pneumonia
Vaccination
Costs and Cost Analysis
African Americans
Population Control
Fees and Charges
Volunteers
Vaccines

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)

Keywords

  • aging
  • cost
  • geriatrics
  • infectious disease
  • pneumonia
  • vaccines

Cite this

Pizzi, Laura ; Prioli, Katherine M. ; Fields Harris, Lynn ; Cannon-Dang, Elizabeth ; Marthol-Clark, Marie ; Alcusky, Matt ; McCoy, Megan ; Schafer, Jason J. / Knowledge, Activation, and Costs of the Pharmacists’ Pneumonia Prevention Program (PPPP) : A Novel Senior Center Model to Promote Vaccination. In: Annals of Pharmacotherapy. 2018 ; Vol. 52, No. 5. pp. 446-453.
@article{090a9a713abd462694141b94362abb3e,
title = "Knowledge, Activation, and Costs of the Pharmacists’ Pneumonia Prevention Program (PPPP): A Novel Senior Center Model to Promote Vaccination",
abstract = "Background: Vaccination is the best way to prevent pneumococcal disease (PD), but 40{\%} of older adults remain unvaccinated nationwide, with even greater nonvaccination rates among African Americans (AAs). Prior studies suggest that insufficient knowledge contributes to low vaccination rates. The Pharmacists’ Pneumonia Prevention Program (PPPP) was designed to improve older adults’ knowledge about PD and pneumococcal vaccination (PV). Objective: To measure PPPP’s effect on knowledge and activation in a predominantly AA population and determine program costs. Methods: PPPP uses a senior center model with a pharmacist presentation, actors’ skit, and small-group action planning. Knowledge about PD risk, transmission, symptoms, and PV side effects was assessed at baseline (BL), postintervention (PT), and 3 months (M3) and analyzed using an intention-to-treat (ITT) approach. Actions taken (got vaccinated, spoke to doctor or pharmacist, discussed with family/friends) were assessed at M3. PPPP costs ($US 2013) included staff time, PV, actor, and site fees. Results: Of 276 attending PPPP, 190 consented and were included in the ITT sample, which was largely black (80.5{\%}) and female (76.3{\%}) and had a mean age of 74.4 years. Knowledge improved by 46.8{\%} (BL vs PT), with significant gains in all domains. At M3, knowledge improved by 54.2{\%} vs BL, indicating sustained gains; 37.2{\%} of previously unvaccinated participants reported receiving PV by M3. Program cost was $119 per attendee. Conclusion: PPPP significantly improved PD and PV knowledge. It could be delivered more efficiently by holding larger events on fewer dates, staffing with volunteers where appropriate, and utilizing a local pharmacy to manage the vaccine supply.",
keywords = "aging, cost, geriatrics, infectious disease, pneumonia, vaccines",
author = "Laura Pizzi and Prioli, {Katherine M.} and {Fields Harris}, Lynn and Elizabeth Cannon-Dang and Marie Marthol-Clark and Matt Alcusky and Megan McCoy and Schafer, {Jason J.}",
year = "2018",
month = "5",
day = "1",
doi = "10.1177/1060028017745566",
language = "English (US)",
volume = "52",
pages = "446--453",
journal = "Annals of Pharmacotherapy",
issn = "1060-0280",
publisher = "Harvey Whitney Books Company",
number = "5",

}

Knowledge, Activation, and Costs of the Pharmacists’ Pneumonia Prevention Program (PPPP) : A Novel Senior Center Model to Promote Vaccination. / Pizzi, Laura; Prioli, Katherine M.; Fields Harris, Lynn; Cannon-Dang, Elizabeth; Marthol-Clark, Marie; Alcusky, Matt; McCoy, Megan; Schafer, Jason J.

In: Annals of Pharmacotherapy, Vol. 52, No. 5, 01.05.2018, p. 446-453.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Knowledge, Activation, and Costs of the Pharmacists’ Pneumonia Prevention Program (PPPP)

T2 - A Novel Senior Center Model to Promote Vaccination

AU - Pizzi, Laura

AU - Prioli, Katherine M.

AU - Fields Harris, Lynn

AU - Cannon-Dang, Elizabeth

AU - Marthol-Clark, Marie

AU - Alcusky, Matt

AU - McCoy, Megan

AU - Schafer, Jason J.

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Background: Vaccination is the best way to prevent pneumococcal disease (PD), but 40% of older adults remain unvaccinated nationwide, with even greater nonvaccination rates among African Americans (AAs). Prior studies suggest that insufficient knowledge contributes to low vaccination rates. The Pharmacists’ Pneumonia Prevention Program (PPPP) was designed to improve older adults’ knowledge about PD and pneumococcal vaccination (PV). Objective: To measure PPPP’s effect on knowledge and activation in a predominantly AA population and determine program costs. Methods: PPPP uses a senior center model with a pharmacist presentation, actors’ skit, and small-group action planning. Knowledge about PD risk, transmission, symptoms, and PV side effects was assessed at baseline (BL), postintervention (PT), and 3 months (M3) and analyzed using an intention-to-treat (ITT) approach. Actions taken (got vaccinated, spoke to doctor or pharmacist, discussed with family/friends) were assessed at M3. PPPP costs ($US 2013) included staff time, PV, actor, and site fees. Results: Of 276 attending PPPP, 190 consented and were included in the ITT sample, which was largely black (80.5%) and female (76.3%) and had a mean age of 74.4 years. Knowledge improved by 46.8% (BL vs PT), with significant gains in all domains. At M3, knowledge improved by 54.2% vs BL, indicating sustained gains; 37.2% of previously unvaccinated participants reported receiving PV by M3. Program cost was $119 per attendee. Conclusion: PPPP significantly improved PD and PV knowledge. It could be delivered more efficiently by holding larger events on fewer dates, staffing with volunteers where appropriate, and utilizing a local pharmacy to manage the vaccine supply.

AB - Background: Vaccination is the best way to prevent pneumococcal disease (PD), but 40% of older adults remain unvaccinated nationwide, with even greater nonvaccination rates among African Americans (AAs). Prior studies suggest that insufficient knowledge contributes to low vaccination rates. The Pharmacists’ Pneumonia Prevention Program (PPPP) was designed to improve older adults’ knowledge about PD and pneumococcal vaccination (PV). Objective: To measure PPPP’s effect on knowledge and activation in a predominantly AA population and determine program costs. Methods: PPPP uses a senior center model with a pharmacist presentation, actors’ skit, and small-group action planning. Knowledge about PD risk, transmission, symptoms, and PV side effects was assessed at baseline (BL), postintervention (PT), and 3 months (M3) and analyzed using an intention-to-treat (ITT) approach. Actions taken (got vaccinated, spoke to doctor or pharmacist, discussed with family/friends) were assessed at M3. PPPP costs ($US 2013) included staff time, PV, actor, and site fees. Results: Of 276 attending PPPP, 190 consented and were included in the ITT sample, which was largely black (80.5%) and female (76.3%) and had a mean age of 74.4 years. Knowledge improved by 46.8% (BL vs PT), with significant gains in all domains. At M3, knowledge improved by 54.2% vs BL, indicating sustained gains; 37.2% of previously unvaccinated participants reported receiving PV by M3. Program cost was $119 per attendee. Conclusion: PPPP significantly improved PD and PV knowledge. It could be delivered more efficiently by holding larger events on fewer dates, staffing with volunteers where appropriate, and utilizing a local pharmacy to manage the vaccine supply.

KW - aging

KW - cost

KW - geriatrics

KW - infectious disease

KW - pneumonia

KW - vaccines

UR - http://www.scopus.com/inward/record.url?scp=85044068267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044068267&partnerID=8YFLogxK

U2 - 10.1177/1060028017745566

DO - 10.1177/1060028017745566

M3 - Article

AN - SCOPUS:85044068267

VL - 52

SP - 446

EP - 453

JO - Annals of Pharmacotherapy

JF - Annals of Pharmacotherapy

SN - 1060-0280

IS - 5

ER -